Fuller & Thaler Asset Management, Inc. Staar Surgical CO Transaction History

Fuller & Thaler Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $256,308 - $405,370	3,633 Added 2.94%	127,121 $8.97 Million
Q2 2022 Aug 12, 2022	BUY	$50.24 - $80.48 $137,657 - $220,515	2,740 Added 2.27%	123,488 $8.76 Million
Q1 2022 May 13, 2022	BUY	$57.98 - $93.5 $7 Million - $11.3 Million	120,748 New	120,748 $9.65 Million
Q2 2019 Aug 13, 2019	SELL	$23.08 - $37.01 $8.49 Million - $13.6 Million	-367,674 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$27.81 - $40.78 $164,162 - $240,724	5,903 Added 1.63%	367,674 $12.6 Million
Q4 2018 Feb 14, 2019	SELL	$28.91 - $50.0 $872,445 - $1.51 Million	-30,178 Reduced 7.7%	361,771 $11.5 Million
Q3 2018 Nov 13, 2018	BUY	$30.85 - $50.65 $1.02 Million - $1.68 Million	33,222 Added 9.26%	391,949 $18.8 Million
Q2 2018 Aug 07, 2018	BUY	$13.95 - $32.65 $5 Million - $11.7 Million	358,727 New	358,727 $11.1 Million

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.